What place for renal denervation in the 2023 Guidelines of the European Society of Hypertension?

Mis à jour le mercredi 20 septembre 2023

The revision of the indication for renal denervation in the ESH 2023 Guidelines is presented as a minor "revolution" by Atul Pathak, who explains that it is because this procedure has been shown over the past 5 years to reduce blood pressure in hypertensive patients, whether untreated, treated or resistant, that it can now be classified as level II B.

Follow the interview with our expert to find out all the details, and to learn more about the two other recommendations of these guidelines: giving priority to specialized centers and shared decision-making process.

This program is offered to you with the institutional support of Recor Medical.

Vidéo précédente

Christophe Leclercq vous convie à l'événement incontournable du mois de janvier !

Vidéo suivante

Insuffisance cardiaque à FEVG réduite nouvellement diagnostiquée : place du gilet défibrillateur dans le contexte de l'actualisation, en 2023, des recommandations 2021 de l'ESC sur la prise en charge de l’insuffisance cardiaque